Endoxifen

内昔芬

Report date: 2026/05/08 17:47:22
NME

Base Information

Drug NameEndoxifen
Drug Alias Name他莫昔芬4-Hydroxy-N-desmethyltamoxifenZ-endoxifen(Z)-endoxifen
ClassificationSmall molecules
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsBipolar I DisorderBipolar DisorderGenital Diseases, Female +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesJina Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteJina Pharmaceuticals IncAtossa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBipolar I DisorderBipolar DisorderGenital Diseases, Female +[8] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A